Cerevel Therapeutics Holdings Inc at Citi BioPharma Conference (Virtual) Transcript
So, good morning, everyone, and thank you for attending Citi's 16th Annual Biopharma Conference. I'm Neena Bitritto-Garg. I'm one of the biotech analysts here, if you don't know me.
And for our next session, I'm really pleased to be joined this morning by leadership from 3 companies developing drugs in the psychiatric disease and broader CNS space as well: Cerevel, Karuna and Praxis Precision Medicines. So from Cerevel, we have CMO, Ray Sanchez; from Karuna, we have Steve Paul, CEO; and from Praxis, we have Marcio Souza, CEO as well. And we'll cover some high-level topics this morning in psychiatry; some specific indications, including schizophrenia, DRP and depression; and some specific programs that each of you are developing as well.
Before we get into the discussion, I just wanted to remind the listeners that if you do have a question, feel free to e-mail me directly or you can actually submit questions here at online portal and I'll receive them as well and I'll try to incorporate them
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
